1. Home
  2. PLAG vs SNGX Comparison

PLAG vs SNGX Comparison

Compare PLAG & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PLAG

Planet Green Holdings Corp.

N/A

Current Price

$0.70

Market Cap

8.6M

ML Signal

N/A

Logo Soligenix Inc.

SNGX

Soligenix Inc.

N/A

Current Price

$0.37

Market Cap

8.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PLAG
SNGX
Founded
1986
1987
Country
United States
United States
Employees
6
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.6M
8.2M
IPO Year
2007
2006

Fundamental Metrics

Financial Performance
Metric
PLAG
SNGX
Price
$0.70
$0.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 636.8K
200.0K
Earning Date
11-13-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
32.56
★ 57.03
EPS
★ N/A
N/A
Revenue
★ $3,040,616.00
$119,371.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.49
$0.28
52 Week High
$6.81
$1.97

Technical Indicators

Market Signals
Indicator
PLAG
SNGX
Relative Strength Index (RSI) 47.16 40.65
Support Level $0.65 $0.35
Resistance Level $0.77 $0.41
Average True Range (ATR) 0.04 0.01
MACD 0.01 -0.00
Stochastic Oscillator 39.13 14.44

Price Performance

Historical Comparison
PLAG
SNGX

About PLAG Planet Green Holdings Corp.

Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).

Share on Social Networks: